Follow our Immune Editing data at
http://www.IsoPlexis.com/CellT-P
Let's discuss how we can work together!
RNR
When Editing
Immune Cells,
The Small Things
Make a Big
Difference
IsoPlexis is showing how small groups of
gene engineered or edited cells make a
big difference in cell product potency.
IsoPlexis, with industry leaders, has
uniquely revealed differences between
Cell Therapy Non-Responders (NR)
versus Responders (R) from the cell
therapy product itself.
See how we’re revealing key differences in
pre-clinical development, manufacturing,
and biomarker discovery to enable what’s
next in cell engineering and therapy.